High-Dose Influenza Vaccine in Nursing Homes

Status unconfirmed · Phase 4

Conditions studied: Influenza

In brief

The purpose of this study is to prospectively evaluate relative effectiveness of high dose influenza vaccine in preventing influenza mortality, hospitalization, and functional decline in a nursing home population in the U.S., compared to the standard dose trivalent seasonal influenza vaccine.

Key facts

Study ID

NCT01815268

Run by

Insight Therapeutics, LLC

People needed

823

Starts

2013-02-01

Expected to finish

2018-09-01

Last updated by the study team

2018-07-16

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Long-term care facilities within 50 miles of one of the 122 cities that serve as CDC surveillance sites

You may not qualify if…

• Facilities already systematically administering HD vaccine to their residents
• Facilities having fewer than 50 long-stay residents
• Hospital-based facilities
• Facilities with more than 20% of the population under age 65
• Facilities not submitting Minimum Data Set (MDS) data

Where it is running

• Case Western Reserve University — Cleveland, Ohio, United States
• Brown University — Providence, Rhode Island, United States
• Insight Therapeutics, LLC — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.